Lung cancer risk and cancer-specific mortality in subjects undergoing routine imaging test when stratified with and without identified lung nodule on imaging study

被引:13
|
作者
Gomez-Saez, Noemi [1 ]
Hernandez-Aguado, Ildefonso [1 ,2 ]
Vilar, Jose [3 ]
Gonzalez-Alvarez, Isabel [4 ]
Fermina Lorente, Maria [4 ]
Luisa Domingo, Maria [3 ]
Pastor Valero, Maria [1 ,2 ]
Anne Parker, Lucy [1 ,2 ]
Lumbreras, Blanca [1 ,2 ]
机构
[1] Miguel Hernandez Univ, Publ Hlth Hist Sci & Ginecol Dept, Alicante, Spain
[2] CIBER Epidemiol & Salud Publ, Madrid, Spain
[3] Peset Hosp, Radiodiagnost Dept, Valencia, Spain
[4] San Juan Hosp, Radiodiagnost Dept, Alacant, Spain
关键词
Solitary pulmonary nodule (SPN); Lung neoplasm; General population; Diagnostic imaging; Mortality; SOLITARY PULMONARY NODULES; PROBABILITY;
D O I
10.1007/s00330-015-3775-3
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
To assess the risk of lung cancer and specific mortality rate in patients with and without solitary pulmonary nodules (SPN) on chest radiograph and CT. This prospective study included 16,078 patients a parts per thousand yen35 years old (893 of them had an SPN detected with either chest radiograph or CT) and 15,185 without SPN. Patients were followed up for 18 months or until being diagnosed with lung cancer. Risk and mortality lung cancer were calculated in both groups with Poisson regression. In patients with SPN, incidence of lung cancer was 8.3 % (95 % CI 6.0-11.2) on radiograph and 12.4 % (95 % CI 9.3-15.9) on CT. A chronic obstructive pulmonary disease in patients with radiographs (odds ratio 2.62; 95 % CI 1.03, 6.67) and smoking habit (odds ratio 20.63; 95 % CI 3.84, 110.77) in patients with CT were associated with a higher probability of lung cancer. Large nodule size and spiculated edge were associated with lung cancer on both CT and radiograph. Lung cancer-specific mortality was lower in patients with SPN than in those without SPN (1.73/1000 person-years, 95 % CI 1.08-2.88 vs. 2.15/1000 person-years, 95 % CI 1.25-3.96). The risk of lung cancer for patients with SPN is higher in clinical populations than in screening studies. Moreover, patients with SPN showed lower mortality than those without SPN. aEuro cent Lung cancer risk is 8 % for SPN detected on routine radiographs. aEuro cent Lung cancer risk is 12.4 % for SPN detected in routine chest CT. aEuro cent Smoking, COPD, SPN diameter and edge were predictors of malignancy. aEuro cent Lung cancer risk of SPN in routine practice seems higher than in screening.
引用
收藏
页码:3518 / 3527
页数:10
相关论文
共 24 条
  • [1] Lung cancer risk and cancer-specific mortality in subjects undergoing routine imaging test when stratified with and without identified lung nodule on imaging study
    Noemi Gómez-Sáez
    Ildefonso Hernández-Aguado
    José Vilar
    Isabel González-Alvarez
    María Fermina Lorente
    María Luisa Domingo
    María Pastor Valero
    Lucy Anne Parker
    Blanca Lumbreras
    European Radiology, 2015, 25 : 3518 - 3527
  • [2] Age increased the cancer-specific mortality risk of thyroid cancer with lung metastasis
    Huang, Xiu
    Xia, Qing
    Huang, Yueye
    Peng, Aimei
    Yang, Jie
    CLINICAL ENDOCRINOLOGY, 2022, 96 (05) : 719 - 727
  • [3] Lung Cancer-Specific Mortality Risk and Public Health Insurance: A Prospective Cohort Study in Chongqing, Southwest China
    Wang, Yuqi
    Lei, Haike
    Li, Xiaosheng
    Zhou, Wei
    Wang, Guixue
    Sun, Anlong
    Wang, Ying
    Wu, Yongzhong
    Peng, Bin
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [4] Menopausal Hormone Therapy and Lung Cancer-Specific Mortality Following Diagnosis: The California Teachers Study
    Clague, Jessica
    Reynolds, Peggy
    Henderson, Katherine D.
    Sullivan-Halley, Jane
    Ma, Huiyan
    Lacey, James V., Jr.
    Chang, Shine
    Delclos, George L.
    Du, Xianglin L.
    Forman, Michele R.
    Bernstein, Leslie
    PLOS ONE, 2014, 9 (07):
  • [5] Based on the Development and Verification of a Risk Stratification Nomogram: Predicting the Risk of Lung Cancer-Specific Mortality in Stage IIIA-N2 Unresectable Large Cell Lung Neuroendocrine Cancer Compared With Lung Squamous Cell Cancer and Lung Adenocarcinoma
    Yang, Ying
    Shen, Cheng
    Shao, Jingjing
    Wang, Yilang
    Wang, Gaoren
    Shen, Aiguo
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] In Vivo Near-Infrared Fluorescence/Ratiometric Photoacoustic Duplex Imaging of Lung Cancer-Specific hNQO1
    Zhang, Xinming
    Jiang, Kejia
    Jiang, Shanshan
    Zhao, Feng
    Chen, Penghang
    Huang, Peng
    Lin, Jing
    ANALYTICAL CHEMISTRY, 2022, 94 (40) : 13770 - 13776
  • [7] Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma
    Eguchi, Takashi
    Kadota, Kyuichi
    Chaft, Jamie
    Evans, Brent
    Kidd, John
    Tan, Kay See
    Dycoco, Joe
    Kolquist, Kathryn
    Davis, Thaylon
    Hamilton, Stephanie A.
    Yager, Kraig
    Jones, Joshua T.
    Travis, William D.
    Jones, David R.
    Hartman, Anne-Renee
    Adusumilli, Prasad S.
    ONCOTARGET, 2016, 7 (23) : 35241 - 35256
  • [8] Risk-stratified screening and colorectal cancer incidence and mortality: A retrospective study from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
    Zhang, Yu
    Sheng, Chao
    Fan, Zeyu
    Liu, Ya
    Liu, Xiaomin
    Duan, Hongyuan
    Dai, Hongji
    Lyu, Zhangyan
    Yang, Lei
    Song, Fangfang
    Song, Fengju
    Huang, Yubei
    Chen, Kexin
    PREVENTIVE MEDICINE, 2024, 187
  • [9] Semi-Sold Lung Nodule Growth Rates, Need for Treatment, and Cancer-Specific Verses All-Cause Mortality in a Large North American Population
    Woodard, G. A.
    Kane, E.
    Prince, S.
    Blasberg, J.
    Dhanasopon, A.
    Boffa, D.
    Mase, V.
    Dacic, S.
    Bader, A.
    Detterbeck, F.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S87 - S87
  • [10] EFFECTIVENESS OF A RISK-STRATIFIED CLINICAL & IMAGING SURVEILLANCE PROTOCOL (LNC-PATH) FOLLOWING SURGICAL RESECTION OF LUNG CANCER
    Brockelsby, C.
    Bradley, P.
    Craig, C.
    Ryan, D.
    Martin, J.
    Lyons, J.
    Sinnott, N.
    Crosbie, P.
    Booton, R.
    Balata, H.
    Evison, M.
    THORAX, 2022, 77 : A18 - A18